Suppr超能文献

相似文献

1
Longitudinal Free-Water Changes in Dementia with Lewy Bodies.
Mov Disord. 2024 May;39(5):836-846. doi: 10.1002/mds.29763. Epub 2024 Mar 13.
2
Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
Cochrane Database Syst Rev. 2015 Jan 30;1(1):CD010633. doi: 10.1002/14651858.CD010633.pub2.
4
A systematic review of diffusion tensor imaging and tractography in dementia with Lewy bodies and Parkinson's disease dementia.
Neurosci Biobehav Rev. 2025 Feb;169:106007. doi: 10.1016/j.neubiorev.2025.106007. Epub 2025 Jan 9.
5
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
6
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
7
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
8
Cholinesterase inhibitors for dementia with Lewy bodies.
Cochrane Database Syst Rev. 2003;2003(3):CD003672. doi: 10.1002/14651858.CD003672.
9

引用本文的文献

本文引用的文献

1
(Dis-)Connected Dots in Dementia with Lewy Bodies-A Systematic Review of Connectivity Studies.
Mov Disord. 2023 Jan;38(1):4-15. doi: 10.1002/mds.29248. Epub 2022 Oct 17.
2
Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations.
Transl Neurodegener. 2022 May 2;11(1):24. doi: 10.1186/s40035-022-00299-w.
4
Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration.
Brain Commun. 2022 Feb 7;4(2):fcac013. doi: 10.1093/braincomms/fcac013. eCollection 2022.
5
Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies.
Mov Disord. 2022 Jun;37(6):1256-1264. doi: 10.1002/mds.28973. Epub 2022 Mar 8.
6
Association of Cognitive Impairment With Free Water in the Nucleus Basalis of Meynert and Locus Coeruleus to Transentorhinal Cortex Tract.
Neurology. 2022 Feb 15;98(7):e700-e710. doi: 10.1212/WNL.0000000000013206. Epub 2021 Dec 14.
7
Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
Brain. 2022 Jun 3;145(5):1773-1784. doi: 10.1093/brain/awab372.
8
Outcome Measures for Dementia With Lewy Body Clinical Trials: A Review.
Alzheimer Dis Assoc Disord. 2022;36(1):64-72. doi: 10.1097/WAD.0000000000000473.
9
Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases.
Int J Mol Sci. 2021 May 14;22(10):5216. doi: 10.3390/ijms22105216.
10
MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease.
J Neuroimaging. 2021 Sep;31(5):1020-1027. doi: 10.1111/jon.12878. Epub 2021 May 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验